Les opportunités dans le domaine de la santé - NCP Wallonie · Les opportunités dans le domaine de la santé Horizon-2020 appels 2018 Les slides seront disponibles sur le site

Les opportunités dans le domaine de la santé

Horizon-2020 appels 2018

Les slides seront disponibles sur le site web du NCP-Wallonie

Emilie ETOUNDI

http://www.ncpwallonie.be/fr/



28/09/2017 - 2 -

! Versions provisoires et non

officiellement adoptées par la

Commission Européenne.

Modifications possibles!!!

- 3 -

Cross-

cutting

activities

- 4 -

Cross-

cutting

activities

28/09/2017

Societal Challenge 1

- 5 -

SC1 “Health, demographic change and well-being”

Call 1: Better health care, economic growth and sustainable health systems

Call 2: Digital transformation in Health and Care

Call 3: Trusted digital solutions and Cybersecurity in Health and Care

28/09/2017

36M€

100M€

442M€

(eHealth: 42M€ )

e-h

ealth


- 6 -

Horizon-2020 SC1 – Projets avec des Wallons

28/09/2017

Towards tailored, needs-

driven, safer and cost-

effective management of

Crohn’s disease

A systems medicine

approach to chronic

inflammatory diseases

Call 1 – Better health and care, economic growth

and sustainable health

Better health and care, economic growth and sustainable health

• Contributing to better health and healthy ageing

• Developing sustainable health and care systems and growth opportunities for the health and care related industries

• Translating new knowledge into innovative applications and accelerating large-scale uptake and deployment in different health and care settings

• Making health and care systems and services more accessible, responsive and efficient in Europe and beyond

5 main priorities

• Personalised medicine

• Innovative health and care industry

• Infectious diseases and improving global health

• Innovative health and care systems – integration of care

• Decoding the role of the environment for health and well-being.

28/09/2017 - 7 -


- 8 - 28/09/2017 8

07.11.2017 18.04.2018 09.2018 Fin 2018

Ouverture appels Dépôt des projets Résultat de l’évaluation

Signature contrat

Structuration idée et budget

Identification partenaires

Rédaction Évaluation Finalisation du

contrat

Exéc

uti

on

du

p

roje

t

Eté 2017

Call 1 – Better health and care, economic growth and sustainable health

- 9 -

28/09/2017

SC1-BHC-03-2018: Exploiting research outcomes and application potential of the human microbiome for personalised prediction and prevention of diseases Define/understand balanced healthy conditions to deliver personalised approaches and clinical tools to predict and prevent diseases • Use of existing data (large scale international initiatives, existing microbiome project) • Generation of new data with various approaches • Collaboration and synergies between scientists across disciplines, sectors and around

the globe • Sex & gender, country-specific issues • Participation of SMEs

: 10-15M€ : 18.04.2018 : 3-5 projets RIA


- 10 -

28/09/2017

SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine

International aspects • Building links with third countries based on advantages of collaboration in PM • Promoting international standards in PM and uptake of PM • 2018: CELAC / 2019: China Regional aspects • Establish and support networking between regions in EU (remote and sparsely

populated regions) • Structure PM application at regional level

Healthcare- and pharma-economic models for PM

• Support new health- and pharma economic models for PM to develop relevant health

financing models

• Analyse mid- and long- term impacts of PM innovative products

• Ensure patients access, data safety and financial sustainabilty of public health

systems

• Based on existing work/initiatives

• Dissemination!

28/09/2017 - 11 -

: 1,5-2M€ : 18.04.2018 : 4 projets CSA


- 12 -

28/09/2017

SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future

Use new knowledge and technologies to introduce greater innovation into the advanced therapy development chain as a basis for tackling diseases and conditions affecting large patients groups.

• Create knowledge and exploitation platforms around innovative concepts for advanced

therapy development build possible new therapeutic approaches and overcome development bottlenecks

• All steps of the innovation chain • Business model for exploiting results + appropriate outreach and public information

activities

: 12-15M€ : 18.04.2018 : 3 projets RIA


- 13 -

28/09/2017

SC1-HCO-05-2018: Strengthen Regulatory Science and support for regulatory Scientific Advice

Better address regulatory sciences in medical teaching and training as well as in biomedical research for innovations to reach the patients in a timely and efficient manner • Comprehensive inventory of existing support activities for regulatory Scientific Advice

and protocol assistance in Europe • Develop and deliver efficient training programmes to strengthen Regulatory Sciences • Mechanisms to support academic groups in regulatory Scientific Advice and protocol

assistance procedures • Coordinate and/or harmonise efforts among MS

: 1,5-2M€ : 18.04.2018 : 1 projet CSA


- 14 -

28/09/2017

SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)

Development of new, more effective and affordable treatments and vaccines for NIDs for uptake by limited-resources health systems. • Late preclinical and early clinical (up to phase 1) • Already existing lead drug and vaccine candidates • Take into account the downstream constraints for effective deployment and uptake • At least one organisation from disease-endemic countries, in particular Latin America

& Africa • Lump sum

: 5-10M€ : 06.02.2018 : 04.09.2018 (2 phases)

: 5-10 projets RIA


- 15 -

28/09/2017

SC1-BHC-16-2018: Global Alliance for Chronic Diseases (GADC) – scaling-up of evidence-based health interventions at population level for the prevention, detection, and management of hypertension and/or diabetes

• Low- and middle-income countries and/or vulnerable populations in high income

countries • Identify best evidence-based interventions implementation and scale-up according

commitments at regional or national level • Address the comorbidities • ! Cost-effectiveness • All stakeholders involved at all stages (including proposal design) • Gender and cultural aspects

: 2-4M€ : 18.04.2018 : 5-10 projets RIA


- 16 -

28/09/2017

SC1-BHC-18-2018: Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC)

Translational and multidisciplinary research to identify specific patient groups in view of improving one or more of the following aspects: screening, early detection, diagnosis and/or prognosis. • Build on the diverse genetic backgrounds, risk factors, cancer incidence, geographical

environment, and/or different healthcare models in European and CELAC countries • Molecular, behavioural, nutritional, clinical, social and environmental epidemiology • Use data from cohorts, biobanks, repositories, research infrastructures • Two participants from two different CELAC countries

: 2-4M€ : 18.04.2018 : 6-12 projets RIA


- 17 -

28/09/2017

SC1-BHC-21-2018: Research on HIV, tuberculosis (TB) and/or hepatitis C (HCV) in patients with mono-, co-infections and/or comorbidities in the context of fostering collaboration with the Russian Federation

Understand and address current epidemiological situation issues to reduce the cases of new

infections and deaths, particularly in vulnerable groups (ageing, drug users…)

• TB: biomarkers or new diagnostics tests for early screening of TB risk groups and identification

of antimicrobial drug resistance

• HIV: susceptibility to HIV and/or disease progression rate

• HCV: genetic determinants of the virus and the host, and comorbid conditions

• Already established European cohort networks + NEW

• Sex & gender

• At least one partner from the Russian Federation

: 2-3M€ : 18.04.2018 (max. 24 months)

: 3-5 projets RIA


- 18 -

28/09/2017

SC1-HCO-06-2018: Establishment of an International Network of Social Sciences Research Centres to help address governance and other challenges in the preparedness for and the response to infectious threats

Establish an International Network of Social Sciences Research Centres, to better address

governance and other challenges in prevention and response to infectious threats, be it at local,

national, regional or global levels

be better prepared to respond to infectious threats.

• Initiate the INSSR addressing governance challenges

• Engage with stakeholders and research funding agencies at an international scale

• Establish the central coordinating hub for the network

• Maximise opportunities for collaboration, learning and data sharing

• Collaboration with existing initiatives

: 2-3M€ : 18.04.2018 : 1 projet CSA


- 19 -

28/09/2017

SC1-HCO-09-2018: Building international efforts on population and patient cohorts Establish a strategy for the development of the next generation of integrated cohorts • Build on existing cohorts • Map the cohort landscape in EU and large international initiatives • Identify best strategies for integration • Define an international strategic agenda for better coordination of cohorts globally • Data collection harmonisation and management • Foster the inclusion of data emerging from new technologies and new type of data • Access to cohorts

: 1-2M€ : 18.04.2018 : 1-2 projets CSA


- 20 -

28/09/2017

SC1-HCO-10-2018: Coordinating European brain research and developing global initiatives

Enhance networking and coordination efforts between the different brain research initiatives, at both

European and global level, in order to minimise fragmentation and duplication as well as facilitate

access to data to enhance the exploitation of results.

• Identify areas of neurosciences which particularly need enhanced coordination of research communities

• Accelerate exchange between researchers

• Facilitate links with research infrastructures and other major initiatives (including European Commission services)

• Explore possibilities for broader scale cooperation (outside Europe)

: 1-2M€ : 18.04.2018 : 1-2projets CSA


- 21 -

28/09/2017

SC1-HCO-11-2018: Strategic collaboration in health research and innovation between EU and China

Support networking between European and Chinese policy makers, programme owners and funders. • Develop a sustainable platform facilitating a constant dialogue on addressing common

health R&I challenges • Identify health challenges, whose solution may benefit from closer bi-lateral and/or

multi-lateral cooperation between EU and China • International cooperation

: 0,8-1M€ : 18.04.2018 : 1 projet CSA


- 22 -

28/09/2017

SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation and/or end-of-life care

Demonstrate the effectiveness and cost-effectiveness of new, improved or specifically adapted

pharmacological and/or non-pharmacological interventions to either relieve symptoms and suffering

caused by life-threatening non-communicable diseases or serious late and long-term side effects of

disease treatments in patients and survivors, or symptoms that occur at the end of life.

• Randomised clinical trials/observational studies

• Children and/or adults

• Prove the feasibility of integrating the proposed interventions in current palliative and/or end-of-

life and/or survivorship care regimes and healthcare systems across Europe

• Sex, gender, age and socio-economic factors + any other factors affecting health equity

: 3-4M€ : 18.04.2018 : 10-14 projet RIA


- 23 -

28/09/2017

SC1-BHC-26-2018: HTA research to support evidence-based healthcare Proposals should develop new or improved methodological approaches and frameworks, and foster methodological consensus-building to address all the following: • Specific types or groups of health technologies • Selected therapeutic areas • Use of real-world data • Implementation • Close liaise with EUnetHTA

: 5-10M€ : 18.04.2018 : 1-2 projets RIA


- 24 -

28/09/2017

SC1-BHC-27-2018: New testing and screening methods to identify endocrine disrupting chemicals New and improved approaches are needed to increase the quality and efficiency of existing

methods to meet demanding and evolving regulatory requirements worldwide

• Improve and harmonise screening and testing protocols/strategies and hazard/risk assessments

• Better and faster tools, methods or models, including high-throughput and in silico methods

• Research on adverse outcomes pathways to human health (in vitro)

• Epidemiological and field monitoring data

• Focus on most urgent regulatory needs: thyroid axis, developmental neurotoxicity, metabolic

disorders, female reproduction and non-genotoxic carcinogenicity…

• Involvement of regulatory bodies + JRC

• International cooperation (OECD, EU…)

: 4-6M€ : 18.04.2018 : 8-12 projets RIA


- 25 -

28/09/2017

SC1-HCO-13-2018: Setting the priorities for a European environment, climate and health research agenda • Establish a research/policy coordination group (science and policy actors in

environment and health from H2020-funded activities; national/EU regulatory bodies; international actors)

• Identify key policy areas requiring scientific support for environment, climate change and health related issues

• Develop a European medium-term research and innovation strategy and agenda • Develop a set of guidelines reflecting current state-of-art for health impact and risk

assessment of environmental factors applicable across key sectors • Engagement of all stakeholders internationally • Clear work plan for 3 years

: 2-3M€ (3 years project)

: 18.04.2018 : 1 projet CSA

28/09/2017 - 26 -

Budget # projets

financés Deadline

SC1–BHC-19-2019: Understanding causative mechanisms in co- and

multimorbidities RIA 4-6M€ 5

02.10.2018

16.04.2019

SC1-BHC-02-2019: Systems approaches for the discovery of combinatorial

therapies for complex disorders RIA

4-6M€

10 02.10.2018

16.04.2019

SC1-HCO-01-2018-2019-2020: Actions in support of the International

Consortium for Personalised Medicine

• International aspects: China

• Standardisation for clinical studies design

CSA 1,5-2M€ 2 16.04.2019

SC1-BHC-07-2019: Regenerative medicine: from new insights to new

applications RIA 6-8M€ 6-7 16.04.2019

SC1-BHC-10-2019: Innovation Procurement: Next generation sequencing (NGS)

for routine diagnosis PCP 9-11M€ 3-4 16.04.2019

SC1-BHC-14-2019: Stratified host-directed approaches to improve prevention,

treatment and/or cure of infectious diseases RIA 6-10M€ 9-15

02.10.2018

16.04.2019

SC1-BHC-19-2019: Implementation research for maternal and child health RIA 2-4M€ 5-10 02.10.2018

16.04.2019

SC1-HCO-08-2019: Creation of a European wide sustainable clinical research

network for infectious diseases CSA 2-3M€ 1 16.04.2019

28/09/2017 - 27 -

Budget # projets

financés Deadline

SC1-BHC-22-2019: Mental health in the workplace RIA 2-4M€ 7-15 02.10.2018

16.04.2019

SC1-BHC-25-2019: Demonstration pilots for implementation of personalised

medicine in healthcare IA

18-20M€

3 02.10.2018

16.04.2019

SC1-BHC-28-2019: The Human Exposome Project: a toolbox for assessing and

addressing the impact of environment on health RIA 8-12M€ 4-6 16.04.2019

- 28 -

Cross-

cutting

activities

28/09/2017


- 29 -

28/09/2017

SC1-NMBP-22-2018: Osteo-articular tissues regeneration Conceive innovative designs and development of innovative user-centred biomaterials enabling the delivery of smart, nanostructured and functionalised tissues for personalised regeneration of bones, cartilages, tendons and joints. • Smart and innovative nanobiomaterials also adaptable to remote control • Materials will perform in host tissues affected by severe inflammatory processes • Technologies: 3D-bioprinting, Stem cells technologies, nanofunctionalisation, 3D-

printable biophotopolymeration, additive manufacturing, electrospinning, cross-cutting KETs

• SSH & user involvement • Cooperation with other projects + accessibility and reusability of data

: 4-6M€ : début 2018? : 4-6 projets RIA

28/09/2017 - 30 -

Budget # projets

financés Deadline

NMBP-21-2020: Custom-made biological scaffolds for specific tissue

regeneration and repair RIA ? ? ?

DT-NMBP-23-2020: Next generation organ-on-chip (RIA) RIA ? ? ?

- 31 -

Cross-

cutting

activities

28/09/2017


- 32 -

28/09/2017

DT-SFS-14-2018: Personalised nutrition Deliver innovative solutions (concepts/tools/products/services) for personalised nutrition advice and/or support that will help consumer to achieve their optimal health and well-being and to adopt long-term healthy and sustainable diets. • Understanding food choice and environment • Focus on the consumer benefits • Integrate all relevant factors (health indicators, nutritional requirements, food composition,

lifestyle, preferences, environment, socio-economic…) • Innovative health and care systems – Integration of care • New, smart digital/ICT applications for all levels of personalization • Limited research, prototyping, testing, demonstrating, piloting and large-scale products

validation • Consumer engagement and acceptance • Ethics, regulatory aspects

: 7M€ : 13.02.2018 : 4 projets RIA

A vous de jouer

- 33 -

28/09/2017

Passer à l’action

- 34 -

28/09/2017

Oser initier des contacts & viser l’excellence

Activer votre réseau

Key-players H2020

Participer à des événements

Proposer des contributions concrètes

et spécifiques au topic

Trouver des projets financés

- 35 -

28/09/2017

Lien vers cette page

http://cordis.europa.eu/projects/home_en.html

28/09/2017 - 36 -

Diffuser son profil

- 37 -

Topic Identifié

Données administratives

Contribution concrète au projet /

Valeur ajoutée

Fiche du NCP Wallonie

« One-page expertise description »

28/09/2017

Diffuser son profil

28/09/2017

http://mm.fitforhealth.eu/

InfoDay “Health”, 07-08.12.17, Brussels

• https://www.b2match.eu/healthBE2017

- 38 -

http://www.healthncp.net/ https://www.imi.europa.eu/

content/partner-search /



https://www.b2match.eu/healthBE2017

https://www.b2match.eu/healthBE2017

http://www.healthncp.net/

http://www.healthncp.net/





Fin

- 39 -

Merci pour votre attention

28/09/2017

Pierre Fiasse (NMBP)

European Project Developer

Horizon 2020 Nano, Materials, Transport &

Aero NCP

Tél: +32 (0) 10.47.19.49

[email protected]

Vos contacts au NCP-Wallonie :

Emilie ETOUNDI

European Project Developer

Horizon 2020 Health, Biotechnology,

Agriculture & Food NCP

Tél : +32 (0) 10.48.50.33

[email protected]

mailto:[email protected]



Documents

Les opportunités dans le domaine de la santé - NCP Wallonie · Les opportunités dans le domaine de la santé Horizon-2020 appels 2018 Les slides seront disponibles sur le site